NCT03327831View on ClinicalTrials.gov

Study of Daylight Photodynamic Therapy With Aminolevulinic Acid for Actinic Keratoses

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

February 28, 2017

Study Completion Date

July 31, 2017

Conditions
Actinic Keratosis
Interventions
DRUG

Aminolevulinic Acid

Topical application followed by activation by ambient sunlight

Trial Locations (1)

92697-2400

University of California, Irvine, Irvine

All Listed Sponsors
lead

University of California, Irvine

OTHER

NCT03327831 - Study of Daylight Photodynamic Therapy With Aminolevulinic Acid for Actinic Keratoses | Biotech Hunter | Biotech Hunter